100 related articles for article (PubMed ID: 3878116)
1. Inhibition of interleukin-2 messenger RNA in mouse lymphocytes by 2'-deoxycoformycin and adenosine metabolites.
Cohen MB; Glazer RI
Ann N Y Acad Sci; 1985; 451():180-7. PubMed ID: 3878116
[No Abstract] [Full Text] [Related]
2. 2'-deoxycoformycin toxicity in murine spleen lymphocytes.
Earle MF; Glazer RI
Mol Pharmacol; 1983 Jan; 23(1):165-70. PubMed ID: 6602939
[No Abstract] [Full Text] [Related]
3. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
Matsumoto SS; Yu J; Yu AL
J Immunol; 1983 Dec; 131(6):2762-6. PubMed ID: 6196398
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppression by 2' deoxycoformycin: studies on the mode of administration.
Sordillo EM; Ikehara S; Good RA; Trotta PP
Cell Immunol; 1981 Sep; 63(2):259-71. PubMed ID: 6974052
[No Abstract] [Full Text] [Related]
5. Comparison of the effects on cultured L1210 leukemia cells of the ribosyl, 2'-deoxyribosyl, and xylosyl homologs of tubercidin and adenosine alone or in combination with 2'-deoxycoformycin.
Cass CE; Selner M; Tan TH; Muhs WH; Robins MJ
Cancer Treat Rep; 1982 Feb; 66(2):317-26. PubMed ID: 6976834
[TBL] [Abstract][Full Text] [Related]
6. Prolongation of mouse and rat pancreatic islet cell allografts by adenosine deaminase inhibitors and adenine arabinoside.
Lum CT; Sutherland DE; Payne WD; Gorecki P; Matas AJ; Najarian JS
J Surg Res; 1980 Jan; 28(1):44-8. PubMed ID: 6767140
[No Abstract] [Full Text] [Related]
7. Effects of pentostatin (2'deoxycoformycin), an inhibitor of adenosine deaminase, on type II collagen-induced arthritis in rats.
Gilbertsen RB
J Immunopharmacol; 1985; 7(3):325-41. PubMed ID: 3877119
[TBL] [Abstract][Full Text] [Related]
8. The effect of deoxycoformycin on bone marrow cells treated with adenosine and deoxyadenosine and hemopoietic growth factors.
Fabian I; Williams Z
Hum Immunol; 1988 Feb; 21(2):81-7. PubMed ID: 3259223
[TBL] [Abstract][Full Text] [Related]
9. Specific immunosuppressive effects of constant infusion of 2'-deoxycoformycin.
Trotta PP; Tedde A; Ikehara S; Pahwa R; Good RA; Balis ME
Cancer Res; 1981 Jun; 41(6):2189-96. PubMed ID: 6972248
[TBL] [Abstract][Full Text] [Related]
10. Increased adenosine deaminase synthesis and messenger RNA activity in deoxycoformycin-resistant cells.
Hunt SW; Hoffee PA
J Biol Chem; 1983 Jan; 258(1):41-4. PubMed ID: 6600234
[TBL] [Abstract][Full Text] [Related]
11. 2-Deoxycoformycin inhibition of intracellular phosphorylation of adenosine in Novikoff rat hepatoma cells.
Plagemann PG; Wohlhueter RM
Biochem Pharmacol; 1981 Mar; 30(5):417-26. PubMed ID: 6971643
[No Abstract] [Full Text] [Related]
12. 2'-deoxycoformycin. A new anticancer agent.
Poster DS; Penta JS; Bruno S; Macdonald JS
Cancer Clin Trials; 1981; 4(2):209-13. PubMed ID: 7018725
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor of 2', 5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
Heike T; Katamura K; Kubota M; Shinomiya K; Mikawa H
Adv Exp Med Biol; 1986; 195 Pt B():683-7. PubMed ID: 3490130
[No Abstract] [Full Text] [Related]
14. 2' Deoxycoformycin and human hemopoietic cells in culture.
Jurjus AR; Ridgeway A; Witz IP
Dev Comp Immunol; 1984; 8(4):931-7. PubMed ID: 6240421
[No Abstract] [Full Text] [Related]
15. Biochemical consequences of treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
Paine RM; Smyth JF; Harrap KR
Adv Exp Med Biol; 1979; 122B():365-71. PubMed ID: 317569
[No Abstract] [Full Text] [Related]
16. The effects of adenosine and 2'-deoxycoformycin on sleep and wakefulness in rats.
Virus RM; Djuricic-Nedelson M; Radulovacki M; Green RD
Neuropharmacology; 1983 Dec; 22(12A):1401-4. PubMed ID: 6607425
[TBL] [Abstract][Full Text] [Related]
17. Immune function in mice exposed to the adenosine deaminase inhibitor 2'-deoxycoformycin during immune system development.
Luebke RW; Lawson LD; Rogers RR; Riddle MM; Smialowicz RJ
Immunopharmacol Immunotoxicol; 1987; 9(2-3):149-61. PubMed ID: 3501794
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacology of arabinofuranosyladenine in combination with deoxycoformycin.
Major PP; Agarwal RP; Kufe DW
Cancer Chemother Pharmacol; 1983; 10(2):125-8. PubMed ID: 6600984
[No Abstract] [Full Text] [Related]
19. Aphidicolin and deoxycoformycin cause DNA breaks and cell death in unstimulated human lymphocytes.
Brox L; Hunting D; Belch A
Biochem Biophys Res Commun; 1984 May; 120(3):959-63. PubMed ID: 6428403
[TBL] [Abstract][Full Text] [Related]
20. Selective immunotoxic effects in mice treated with the adenosine deaminase inhibitor 2'-deoxycoformycin.
Luebke RW; Lawson LD; Rogers RR; Riddle MM; Rowe DG; Smialowicz RJ
Immunopharmacology; 1987 Feb; 13(1):25-35. PubMed ID: 2952620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
